,PSURYLQJSDWLHQWSURYLGHUFRPPXQLFDWLRQWRUHGXFH
PHQWDOKHDOWKGLVSDULWLHV&'$
1&7
)HEUXDU\
Please see the published study  protocol paper for additional information . 
Eliacin J  , Burgess DJ  , Rollins AL  , Patterson S  , Damush T  , Bair MJ  , Salyers MP  , Spoont M  , Slaven 
JE , O'Connor C  , Walker K  , Zou DS  , Austin E  , Akins J  , Miller J , Chinman M  , Matthias MS  
Proactive, Recovery -Oriented Treatment Navigation to Engage Racially Diverse Veterans in Mental 
Healthcare (PARTNER -MH), a Peer -Led Patient Navigation Intervention for Racially and Ethnically 
Minoritized Veterans in Veterans Hea lth Administration Mental Health Services: Protocol for a Mixed 
Methods Randomized Controlled Feasibility Study  
JMIR Res Protoc 2022;11(9):e37712  
doi: 10.2196/[ZIP_CODE] PMID:  36066967 PMCID:  9490546  
Research Background  
Low patient engagement in care and ineffective patient -provider communication are 2 major 
contributors to health care disparities [1 -6]. Minoritized patients are less likely to be engaged in 
care, particularly in mental health care [5 -7], which often leads to lower health service use [8 -
10], higher treatment dropout ra tes [5,11,12], and worse clinical outcomes [13]. Reasons for 
low engagement in mental health care vary but include perceived futility of treatment, 
inadequate access to care, lack of culturally sensitive treatment, low self -efficacy, and lack of 
trust in h ealth care systems [14 -16]. Minoritized patients are also more likely to experience 
poor patient -provider communication [1,17] and be excluded from treatment decisions [18]. 
Studies have found patient -provider interactions to be marked by [CONTACT_617419], percep tions of 
discrimination, and provider dominance [18]. Ineffective patient -provider communication 
perpetuates racial health care disparities by [CONTACT_617420] [19 -21], low 
treatment adherence [22], and negative health outcomes [23].  
PARTNER -MH Intervention  
PARTNER -MH incorporates peer support and patient navigation care models to deliver a 
manualized patient activation, engagement, and communication intervention to racially and 
ethnically minoritized Veterans in VHA outpatient mental h ealth clinics. The aims of PARTNER -
MH are as follows: (1) to engage racially and ethnically minoritized patients in mental health 
care, (2) to increase patient activation by [CONTACT_617421] [STUDY_ID_REMOVED] Improving Patient-Provider Communication to Reduce Mental Health Disparities February 7, 2018
collaborators in their care, and (3) to  improve patientsâ€™ communication skills and participation 
in shared treatment decision -making.  
Study Objectives  
Aim 1 (primary aim) is to assess the feasibility and acceptability of PARTNER -MH in a VHA 
mental health care setting.  
Aim 2 is to evaluate the p reliminary effects of PARTNER -MH on patient activation, patient 
engagement, and shared decision -making ( SDM ). We hypothesize that patients randomized to 
the PARTNER -MH intervention group will report greater patient engagement, patient 
activation, and SDM t han patients randomized to the control group.  
Aim 3 is to examine patient -perceived barriers to and facilitators of engagement in PARTNER -
MH as well as contextual factors, using the Consolidated Framework for Implementation 
Research (CFIR) [32], that may i nhibit or promote the integration, sustainability, and scalability 
of PARTNER -MH.  
Methods  
Design Overview  
This pi[INVESTIGATOR_299048] a convergent mixed methods design [33] that involved a randomized 
controlled trial comparing the PARTNER -MH intervention with a wait -list control group with a 
sample of [ADDRESS_819906] 
completed the PARTNER -MH training program. The training program consists of 40 hours of 
didactic sessions that cover topi[INVESTIGATOR_617416], patient engagement, social 
determinants of health, diversity and racial discrimina tion in health care, effective 
communication, and professional development.  
Adherence to Intervention Protocol  
Fidelity assessment was conducted quarterly using a sample of 8 patients in the active group 
(8/29, 28%) stratified by [ADDRESS_819907] deviations from study 
procedures. In addition, peers receive weekly supervision to reinforce training information, 
address challenges, and provide support (aim 1).  
PARTNER -MH Development and Intervention St ructure  
PARTNER -MH is a theory -driven, peer -led intervention that was developed using participatory 
approaches [34,35] guided by [CONTACT_524958] [32]. Specifically, this process involved the active 
participation of racially diverse Veterans, peers, and peer super visors throughout the 
development and pre -implementation phases of PARTNER -MH [36].  
PARTNER -MH is a [ADDRESS_819908] (1) 
belong to a racially or ethnically minoritized group, ( 2) be aged â‰¥18 years, and (3) have a new 
medication management or therapy appointment scheduled within [ADDRESS_819909] recently re -established treatment after an absence of 2 years. 
Veterans are excluded if they  (1) have me ntal or cognitive impairments that limited their ability 
to give consent (eg, having acute psychotic symptoms or being cognitively impaired during the 
consent or interview process), (2) have hearing difficulties that prevent participation in the 
interviews , or (3) received medication management services at the clinic for >[ADDRESS_819910]. In the absence of such notification, 10 days after the 
letterâ€™s receipt was expected, study staff called the patient to explain the study in greater 
detail, conduct initial screening, and ask eligible patients whether they  wished to participate. 
Other recruitment strategies included clinician referrals, patient self -referrals, direct 
advertisements, and snowball sampling (ie, asking enrolled participants to refer others). All 
eligible patients were given a research packet t hat included an invitation letter and a study 
information sheet.  
Ethical Considerations  
Approval was obtained from the Indiana University Institutional Review Board in November 
2017 ([PHONE_12787]) and the Veterans Affairs (VA) Research and Development review  
committee. Protocol modifications will undergo further review by [CONTACT_21917], be communicated to the research team, and updated in the clinical trials registry.  
Randomization and Protection Against Sources of Bias  
Participants completed baseline assessment before being randomized into the study arms to 
ensure balance and reduce selection bias. Allocation to the treatment arm was carried out 
using a computer -generated randomization list with randomly varying block sizes of [ADDRESS_819911] because of the studyâ€™s limited staffing and the need to collect participant feedback on 
the feasibility and acceptability of the intervention, study pers onnel involved in screening and 
enrollment were masked to the computer -generated randomization assignment and were not 
included in delivering the intervention. Moreover, peers were not involved in data collection 
and did not have access to participantsâ€™ as sessment results.  
Wait -list Control Structure and Overview  
Participants in the wait -list control group received regular VHA mental health services (eg, 
individual or group psychotherapy, consults, and medication management) for the 6 months 
after enrollmen t. To overcome potential issues of contamination, where a peer could deliver 
PARTNER -MH services to control group participants, participants in the control group were 
encouraged not to use peer services unless they dropped out of the study. Chart reviews w ere 
conducted to assess contamination.  
Data Collection Methods, Data Management, and Monitoring  
The data collection for this study is ongoing. Screening, enrollment, and survey data were 
collected and stored via VA REDCap (Research Electronic Data Capture;  Vanderbilt University), 
behind the VA firewall. Outcomes were assessed over the phone at baseline and at 3, 6 
(primary end point), 9, and 12 months. Outcome data also included qualitative interviews to 
evaluate participantsâ€™ experience of the intervention  and organizational factors that may 
impact its future implementation and the integration of the quantitative and qualitative data. 
Study participants were compensated with a US $[ADDRESS_819912] for each assessment except for 
the primary end point (at 6 month s), for which they received a US $[ADDRESS_819913]. In addition, 
because of the COVID -19 in -person visit restrictions, participants received a US $[ADDRESS_819914] for 
each month they remained enrolled in the study to facilitate access to telehealth delivery of th e 
intervention and retention. A brief exit survey was sent to participants who discontinued the 
study to evaluate their experiences in the program. Participantsâ€™ enrollment in the study was 
recorded in their medical records, which peers had access to. A da ta safety and monitoring 
board was also established to evaluate the data quality and safety of the study.  
Aim 1 Outcomes  
Aim 1 is to assess the feasibility and acceptability of PARTNER -MH in a VHA  mental health care 
setting.  
The feasibility of PARTNER -MH will be determined based on participantsâ€™ recruitment, 
enrollment, and retention rates. Program acceptability for participants will be evaluated using 
session attendance, number of contacts with peer navigators, and the Patient Satisfaction 
Survey, which i s an 11 -item questionnaire rated on a 3 -point Likert scale ranging from 1 (not at 
all) to 3 (very). Satisfaction with the peer was evaluated using a survey that included questions 
about the patientâ€™s relationship with the peer and views of support provided  by [CONTACT_617422]. 
Descriptive summaries of recruitment, enrollment, retention, and satisfaction rates will be 
reported. Participant feedback from qualitative interviews will also be used to inform the 
feasibility and acceptability of PARTNER -MH (aim 3).  
Aim 2  Outcomes  
Overview  
Aim 2 is to evaluate the preliminary effects of PARTNER -MH on patient engagement, patient 
activation, and SDM . 
Aim 2 has three main outcome measures: patient activation, patient engagement, and SDM. In 
addition, sociodemographic data (e .g., age, sex, race, ethnicity, education, and marital status) 
were collected at baseline. Tertiary and health -related outcomes that included communication 
self-efficacy, depression, mental health, and physical health functions were also assessed at all 
time points and are listed in the Tertiary Outcomes section.  
Secondary Outcomes  
The Patient Activation Measure for Mental Health (PAM -MH)  [37] is a 13 -item questionnaire 
that measures an individualâ€™s perceived ability to manage illness and health behaviors. The 
PAM -MH is reliable, valid, and sensitive to change and correlates with measures of improved 
self-management and health outcomes. The questions are rated on a [ADDRESS_819915] reliability and internal consistency (Cronbach Î±=.91).  
Patient engagement will be assessed using the Altarum Consumer Engagement (ACE)  measure, 
a [ADDRESS_819916] patientsâ€™ commitment to everyday 
health behaviors, navigation skills in using health care services, and informed choice in 
treatment decisions [38]. The ACE is administered as a 5 -level Likert scale. The subscale scores 
range from 5 to 25, and the total engagement score is comput ed by [CONTACT_233563] 3 subscale 
scores and multiplying the sum by 4/3 to obtain a possible range score of 20 to 100. Higher 
scores represent higher patient engagement.  
Finally, we will administer the SDM -Q-9, a widely used 9 -item patient -reported SDM measure 
that focuses on the decisional process by [CONTACT_617423]â€™ behaviors in medical encounters. For 
this study, we will ask participants to think of their most recent visit with their mental health 
provider. The scale shows good internal consistency (Î±=.94) an d high face and structural validity 
[39,40]. The SDM -Q-9 is rated on a 6 -point Likert scale. The items are scored from 0 to 5 on a 6 -
point Likert scale ranging from â€œcompletely disagreeâ€ (0) to â€œcompletely agreeâ€ (5). A simple 
sum score with possible value s between 0 and 45 is obtained. Item means range from 2.9 to 
3.81, and the mean sum of SDM -Q-9 is 3.15 (SD 0.9) [41]. In addition to the SDM -Q-9, we added 
four questions to evaluate patient participation in treatment decision -making: (1) To the extent 
that SDM took place during your visit, how much did you drive the process? (2) Thinking about 
your goal for the visit (what you wanted to be done), how much do you feel you accomplished? 
(3) How much did you feel heard during your discussion with your provider ? (4) Did you 
experience any barriers that kept you from speaking up or participating in SDM during that 
visit?  
Tertiary Outcomes  
Loneliness  was assessed using the University of [LOCATION_004] Los Angeles Loneliness Scale Short 
Form, a 6 -item scale with a 4 -point Likert scale ranging from 1 (never) to 4 (often). It has 
demonstrated internal consistency (Î±.89 -.94) and test -retest reliability ( r=0.73) [42].  
The Perceived Efficacy in Patient -Physician Interaction -5 (PEPPI -5) scale  measures patientsâ€™ self -
efficacy in obtaining medical information and attention to their chief health concern from a 
physician [43]. The PEPPI -5 is 5 -item scale scored on a 5 -point Likert scale ranging from 1 (not 
confident at all) to 5 (very confident). Higher scores indicate higher leve ls of self -efficacy. The 
PEPPI -5 has internal consistency (Î±=.92) and adequate test -retest reliability.  
The Working Alliance Inventory -Short Revised  evaluates three key aspects of the therapeutic 
alliance between patients and their mental health providers: (1) agreement on the tasks of 
therapy, (2) agreement on the goals of therapy, and (3) development of an affective bond 
[44,45]. The Working Allianc e Inventory -Short Revised  includes 12 items rated on a 5 -point 
Likert scale ranging from 1(never) to 5(always). It shows good psychometric properties in both 
outpatient and inpatient populations, with a reliability of Cronbach Î±>.90 and convergent 
validity  with the helpi[INVESTIGATOR_617417] ( r>0.064).  
The Patient Health Questionnaire -9 measures the severity of depressive symptoms. The Patient 
Health Questionnaire -9 includes 9 items and demonstrates high internal consistency and 
reliability (Cronbach Î±= .89) and good sensitivity and specificity for identifying cases of 
depression and assessing depression symptom severity [46].  
The Veterans RAND 12 -item Health Survey measures physical function, social function, role 
limitations owing to physical and emotio nal problems, mental health, energy and vitality, bodily 
pain, and the general perception of health. The Veterans RAND 12 -item Health Survey  uses 5 -
point ordinal response choices and provides two scores: the physical component summary 
score and the mental health summary score [47].  
The Perceived Discrimination in Healthcare Questionnaire  is a 7 -item questionnaire that 
assesses a respondentâ€™s overall health care experiences rather than a specific experience based 
on their racial background. Respondents are a sked to rate their experiences on a 5 -point Likert -
type scale, with answers ranging from 0 (never) to 4 (always). This questionnaire has shown 
excellent reliability in diverse patient populations [48].  
Veteransâ€™ trust in the VA  is assessed using a [ADDRESS_819917] 80% power at a .[ADDRESS_819918] siz e of 0.778 and a difference of 10.8 for PAM -MH changes. To account for 25% 
attrition during follow -up, the study enrolled [ADDRESS_819919] tests for continuous and categorical 
variables, respectively, will be used to compare the demographic and baseline data between 
participants with and without complete data. Repeated measures ANOVA (RMANOVA) f or the 
scale scores will be used to compare data among the assessments over time. The RMANOVAs 
will allow different correlations between each assessment time and will allow for the 
appropriate covariance structure to model the intraparticipant correlations ; they will also 
include a random effect for peers to account for correlation among participants with the same 
peer. In this intent -to-treat analysis, the RMANOVAs will provide unbiased estimates under the 
missing -at-random assumption. A 5% significance le vel will be used for each test.  
Planned Mixed Methods Analysis for Aim 2  
As depi[INVESTIGATOR_6517] 3, this study uses a convergent mixed methods design [33], which involves 
simultaneously collecting quantitative and qualitative data and giving equal weight to these 
data in analyses for the purposes of gaining breadth and depth of understanding (ie, 
complementarity), identifying whether the qualitative and quantitative data provide the same 
answer to the same question (ie, convergence), and using qualitative dat a to expand on 
unexpected quantitative findings (explanatory) [49 -51]. Planned mixed data analysis will involve 
merging and comparing quantitative and qualitative data in parallel to interpret and explain the 
findings (QUAL+QUAN). This approach will enable  us to triangulate our data by [CONTACT_617424] -structured interviews and results from the self -report measures to 
validate our findings, especially in the context of this feasibility study. Many of the constructs 
assessed in the quantita tive measures will also be explored in the qualitative interviews, for 
example, intervention characteristics (patient engagement, patient activation, and 
communication). Moreover, we will use an explanatory mixed methods approach consistent 
with a randomiz ed controlled trial to better understand the quantitative findings, the process of 
the intervention, and participantsâ€™ experiences. The qualitative data will enhance the 
quantitative analyses by [CONTACT_617425].  
Aim 3 Outcomes and Analysis  
Overview  
Aim 3 is to examine patient -perceived barriers to and facilitators of engagement in PARTNER -
MH, as well as contextual factors that may inhibit or promote the in tegration, sustainability, 
and scalability of PARTNER -MH using the CFIR [32].  
We will use domains of the CFIR [32] to collect and analyze data to inform aim 3. The CFIR 
offers an overarching typology of five domains affecting intervention development and 
implementation: (1) intervention characteristics, (2) inner setting, (3) outer setting, (4) 
characteristics of individuals, and (5) implementation process [32]. Briefly, intervention 
characteristics include evidence of the intervention and its adaptability.  Implementation takes 
place within an inner setting â€”the program providing the service. The inner setting is affected 
by [CONTACT_617426] â€”the broader treatment system. Characteristics of individuals such as their 
skills level also affect intervention deliv ery and implementation. The implementation process 
involves different strategies and tools that are used for putting a new practice in place.  
Data collection for aim [ADDRESS_819920] of the program on Veteran outcomes.  
Aim 3 Study Participants  
We will invite all 30 Veterans from the intervention group to participate in a qualitative 
interview. In addition, we will include a purpos eful sample of 5 mental health staff members 
(prescribing and nonprescribing clinicians) with experience in working with peers and patients 
enrolled in the program.  
Aim 3 Planned Qualitative Data Analysis  
Interviews from aim 3 will be transcribed, deidentified, and entered into NVivo (QSR 
International) , a qualitative analytical software program, to help organize the data. To facilitate 
the completion of qualitative data coding and analysis in a short time frame, we will 
incorporate several features recommended in rapid qualitative assessment [ 53]. First, we will 
impose some structure on the data being analyzed. The interviews will reflect CFIR  constructs, 
which will allow for easier access to apply coding. Second, we will incorporate selected codes a 
priori, based on our prior research, to provide initial structure to the coding process, but will 
also allow for the expansion of the code list in which other meaningful ideas may emerge. We 
will use an inductiv e, interpretive approach that borrows concepts from grounded theory, to 
identify and explore emerging areas not covered by [CONTACT_617427].  
Through an iterative, consensus -building process, we will review transcripts to identify 
emergent themes consis tent with techniques of immersion and crystallization [54]. We will 
independently read a few selected documents to identify possible areas of pursuit. We will 
create epi[INVESTIGATOR_617418] -depth understanding of each case and  
identify emerging themes for cross -transcript comparison. We will meet to discuss our findings 
and develop a working set of codes to add to the structural codes mentioned earlier. We will 
repeat this process on fresh sets of documents until we have a set of defined codes that are 
stable and consistent.  We will then code individual transcripts independently.  
To facilitate the rigor of the data analysis process, we plan to hold regular meetings with the 
coding team to examine coding across analysts, resolve differences in coding, identify and 
resolve coding drift, and conduct iterative refinement of code definitions. We will maintain 
memos of our coding processes, coding decisions, and analyses. We will also continually assess 
and maintain consistency and con sensus in our coding practices [ 50,55 ]. 
 
 